FibroGen
FGEN
$1.12
Share price
8.17%
Change (1 day)
-93.43%
Change (1 year)
Categories
FibroGen (FGEN) - Net assets
Net assets on the balance sheet as of December 2023 : -$0.17 B
According to FibroGen's latest financial reports the company has -$0.17 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
FibroGen - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $-0.17 B | 10859.39% |
| 2022-12-31 | $-1.48 M | -100.65% |
| 2021-12-31 | $0.22 B | -48.1% |
| 2020-12-31 | $0.44 B | -17.55% |
| 2019-12-31 | $0.53 B | 1.31% |
| 2018-12-31 | $0.52 B | -3.52% |
| 2017-12-31 | $0.54 B | 212.8% |
| 2016-12-31 | $0.17 B | -11.03% |
| 2015-12-31 | $0.19 B | -18.22% |
| 2014-12-31 | $0.24 B | 123.67% |
| 2013-12-31 | $0.10 B | -11.93% |
| 2012-12-31 | $0.12 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | $5.74 B | -3,641.95% | 🇺🇸 USA |
 Accelerate Diagnostics AXDX | -$19.89 M | -87.74% | 🇺🇸 USA |